Analyst Rating
based on 2 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 2 analysts offering long term price targets for Thyrocare Technologies Ltd. An average target of ₹800
Source: S&P Global Market Intelligence
Thyrocare Technologies Ltd Share analysis
Thyrocare Technologies Ltd price forecast by 2 analysts
Downside of
High
₹825
Target
₹800.00
Low
₹775
Thyrocare Technologies Ltd target price ₹800, a slight downside of -6% compared to current price of ₹831.05. According to 2 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Thyrocare Technologies Ltd revenue growth forecast
Expected growth rate Q1, FY2026:32.20%
Forecast
Actual
Including amortisation and stock based compensations
Thyrocare Technologies Ltd EPS growth forecast
EPS estimate Q1, FY2026:82.63%
Forecast
Actual
Source: S&P Global Market Intelligence
Performance
Day's Low
Day's High
₹822.15₹861.652 Week's Low
52 Week's High
₹506.8₹931.35
| Returns % | |
| 1 Month Return | -3.93 % |
| 3 Month Return | + 33.46 % |
| 1 Year Return | + 48.19 % |
| Market Stats | |
| Previous Close | ₹851.05 |
| Open | ₹856.35 |
| Volume | 73.47K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹4,506.54Cr |
Key Statistics
| P/E Ratio | 57.97 |
| PEG Ratio | 23.38 |
| Market Cap | ₹4,506.54 Cr |
| P/B Ratio | 6.54 |
| EPS | 13.12 |
| Dividend Yield | 0 |
| Sector | Healthcare |
| ROE | 13.75 |
Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹4,506.54 Cr | 14.57% | 0.54 | ₹69 Cr | ₹571 Cr | |
| BUY | ₹9,269.87 Cr | 9.13% | 0.64 | ₹119 Cr | ₹547 Cr | |
| HOLD | ₹10,942.14 Cr | 14.92% | 0.58 | ₹128 Cr | ₹1,207 Cr | |
| HOLD | ₹27,046.72 Cr | 31.93% | 0.55 | ₹362 Cr | ₹2,226 Cr | |
| HOLD | ₹26,170.79 Cr | 122.66% | 0.67 | ₹168 Cr | ₹5,040 Cr |
Mutual Fund Holdings
Company Information
Share Price: ₹831.05 per share as on 19 Sep, 2024 04:01 PM
Market Capitalisation: ₹4,506.54Cr as of today
Revenue: ₹156.91Cr as on June 2024 (Q2 24)
Net Profit: ₹23.94Cr as on June 2024 (Q2 24)
Listing date: 09 May, 2016
Chairperson Name: Rahul Guha
| Organisation | Thyrocare Technologies Ltd |
| Headquarters | Navi Mumbai |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Thyrocare Technologies Ltd
Thyrocare Projects Growth Amid Strategic Acquisitions - 05 Sep, 2024
Thyrocare anticipates mid-teen topline growth for FY25, supported by recent acquisitions including Vimta Labs. The company remains cautious but sees stable margins and minimal competition in tier-2 cities, with shares rising 60% over the past year.
Thyrocare Acquires Vimta Labs' Diagnostic Services - 30 Aug, 2024
Thyrocare Technologies has signed a Business Transfer Agreement to acquire Vimta Labs' diagnostic and pathological services for ₹7 crore, gaining access to 11 centers across multiple states. This strategic move aims to strengthen Thyrocare's market position in southern India and expand its customer base.
Insights on Thyrocare Technologies Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 3 quarters, 15.35 Cr → 24.17 Cr (in ₹), with an average increase of 20.1% per quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 11.10% to 11.50% in Jun 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 137.6 Cr → 160.52 Cr (in ₹), with an average increase of 7.3% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Max Healthcare Institute Ltd has given 158.0% return, outperforming this stock by 190.4%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 71.11% of holdings in Jun 2024 quarter
- NO EFFECT
Against Peers
In the last 1 year, Fortis Healthcare Ltd has given 76.1% return, outperforming this stock by 27.9%
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 12.94% to 12.84% in Jun 2024 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 2.90% to 2.49% in Jun 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 3 years, THYROCARE stock has moved down by -32.4%
Company Financials
Index Inclusions
Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 71.11% | 0.00 | |
| Foreign Institutions | 2.49% | ||
| Mutual Funds | 12.84% | ||
| Retail Investors | 11.5% | 3.57 | |
| Others | 2.06% | 5.74 |
Key Indicators
Thyrocare Technologies Ltd Valuation
Thyrocare Technologies Ltd in the last 5 years
Lowest (18.71x)
June 23, 2022
Today (57.97x)
September 18, 2024
Industry (96.56x)
September 18, 2024
Highest (91.79x)
October 27, 2020
Earnings and Dividends
Thyrocare Technologies Ltd Earnings Results
Thyrocare Technologies Ltd’s net profit jumped 39.71% since last year same period to ₹24.17Cr in the Q1 2024-2025. On a quarterly growth basis, Thyrocare Technologies Ltd has generated 35.94% jump in its net profits since last 3-months.
Read More about Earnings ResultsThyrocare Technologies Ltd Dividends May,2024
In the quarter ending March 2024, Thyrocare Technologies Ltd has declared dividend of ₹18 - translating a dividend yield of 2.12%.
Read More about Dividends
Technicals Summary
Bearish
Neutral
Bullish
Thyrocare Technologies Ltd is currently in a Bearish trading position according to technical analysis indicators.
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Thyrocare Technologies Ltd shares.
Thyrocare Technologies Ltd (THYROCARE) share price today is ₹831.05
Thyrocare Technologies Ltd is listed on NSE
Thyrocare Technologies Ltd is listed on BSE
- Today’s highest price of Thyrocare Technologies Ltd is ₹861.6.
- Today’s lowest price of Thyrocare Technologies Ltd is ₹822.15.
PE Ratio of Thyrocare Technologies Ltd is 57.97
PE ratio = Thyrocare Technologies Ltd Market price per share / Thyrocare Technologies Ltd Earnings per share
Today’s traded volume of Thyrocare Technologies Ltd(THYROCARE) is 73.47K.
Today’s market capitalisation of Thyrocare Technologies Ltd(THYROCARE) is ₹4506.54Cr.
| Thyrocare Technologies Ltd(THYROCARE | Price |
|---|---|
52 Week High | ₹931.35 |
52 Week Low | ₹506.8 |
Thyrocare Technologies Ltd(THYROCARE) share price is ₹831.05. It is down -10.77% from its 52 Week High price of ₹931.35
Thyrocare Technologies Ltd(THYROCARE) share price is ₹831.05. It is up 63.98% from its 52 Week Low price of ₹506.8
| Thyrocare Technologies Ltd(THYROCARE | Returns |
|---|---|
1 Day Returns | -20% |
1 Month Returns | -3.93% |
3 Month Returns | 33.46% |
1 Year Returns | 48.19% |